Vimab Group AB (publ)

OM:VIMAB Stock Report

Market Cap: SEK 77.0m

Vimab Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Peter Fredell

Chief executive officer

SEK 4.3m

Total compensation

CEO salary percentage77.72%
CEO tenure6.3yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Analysis Article • Jan 14

Investors Give Vimab Group AB (publ) (STO:VIMAB) Shares A 26% Hiding

To the annoyance of some shareholders, Vimab Group AB (publ) ( STO:VIMAB ) shares are down a considerable 26% in the...
Analysis Article • Sep 10

It's A Story Of Risk Vs Reward With Vimab Group AB (publ) (STO:VIMAB)

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Professional Services industry in Sweden, you...
Analysis Article • Feb 16

Take Care Before Jumping Onto Vimab Group AB (publ) (STO:VIMAB) Even Though It's 26% Cheaper

Vimab Group AB (publ) ( STO:VIMAB ) shares have retraced a considerable 26% in the last month, reversing a fair amount...
Analysis Article • Dec 22

Vimab Group AB (publ) (STO:VIMAB) Soars 29% But It's A Story Of Risk Vs Reward

Vimab Group AB (publ) ( STO:VIMAB ) shares have had a really impressive month, gaining 29% after a shaky period...
Analysis Article • Nov 06

Vimab Group AB (publ)'s (STO:VIMAB) Shares Not Telling The Full Story

There wouldn't be many who think Vimab Group AB (publ)'s ( STO:VIMAB ) price-to-sales (or "P/S") ratio of 0.7x is worth...
Analysis Article • Mar 14

We Think Vimab Group (STO:VIMAB) Is Taking Some Risk With Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

CEO Compensation Analysis

How has Peter Fredell's remuneration changed compared to Vimab Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-SEK 102m

Sep 30 2025n/an/a

-SEK 91m

Jun 30 2025n/an/a

-SEK 97m

Mar 31 2025n/an/a

-SEK 90m

Dec 31 2024SEK 4mSEK 3m

-SEK 77m

Sep 30 2024n/an/a

-SEK 39m

Jun 30 2024n/an/a

-SEK 23m

Mar 31 2024n/an/a

-SEK 12m

Dec 31 2023SEK 2mn/a

-SEK 4m

Sep 30 2023n/an/a

-SEK 14m

Jun 30 2023n/an/a

-SEK 26m

Mar 31 2023n/an/a

-SEK 27m

Dec 31 2022SEK 2mn/a

-SEK 34m

Compensation vs Market: Peter's total compensation ($USD460.73K) is above average for companies of similar size in the Swedish market ($USD322.67K).

Compensation vs Earnings: Peter's compensation has increased whilst the company is unprofitable.

CEO

Peter Fredell (60 yo)

6.3yrs
Tenure
SEK 4,272,000
Compensation

Mr. Peter Fredell serves as Chief Executive Officer at Vimab Group AB (publ) (formerly known as Headsent AB (publ)) since 2020 and also serves as its Director since 2022. He served as the Chief Executive O...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Fredell
CEO & Director6.3yrsSEK 4.27mno data
Anna Bonde
Chief Financial Officer5.3yrsno datano data
Markus Anglered
Deputy CEO & COO3.3yrsno data7.81%
SEK 6.0m
Rickard Nyberg
Technical Manager3.3yrsno data0.0061%
SEK 4.7k
Jockum Nilsson
C. I. O2.3yrsno data0.028%
SEK 21.6k
3.3yrs
Average Tenure
49yo
Average Age

Experienced Management: VIMAB's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Peter Fredell
CEO & Director4.3yrsSEK 4.27mno data
Gunnar Jardelöv
Independent Chairman of the Board4.3yrsSEK 300.00kno data
Mats Johansson
Director1.3yrsno datano data
4.3yrs
Average Tenure
62yo
Average Age

Experienced Board: VIMAB's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/07 11:44
End of Day Share Price 2026/05/07 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vimab Group AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.